Estonian Defence Forces Report issue

Government

Organization Overview

First Clinical Trial
2016
NCT04359524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Estonian Defence Forces

Active Ingredients

Drugs in Other Trials (1)

vitamin d3 (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1